Recursion Pharmaceuticals, Inc. (RXRX) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
RXRX Historical Performance
Short-Term Returns
RXRX Stock Price Trajectory (2021–2026)
As of May 8, 2026, Recursion Pharmaceuticals, Inc. (RXRX) trades at $3.27, representing a -22.0% return over the past year. The stock has delivered a -88.2% total return over five years (-34.8% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $42.81 on July 13, 2021. From this peak, RXRX has corrected -92.4%, currently trading 27% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers SDGR (-44.0% 1Y), ABCL (+139.8% 1Y), and RLAY (+324.1% 1Y), RXRX has underperformed the peer group average. Compare RXRX vs SDGR →
RXRX Historical Price Data (2025–2026)
Showing 30 of 1,273 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 3.35 | 3.52 | 3.26 | 3.27 | 11.86M | -4.66% |
| 2026-05-06 | 3.19 | 3.44 | 3.14 | 3.43 | 17.54M | +1.78% |
| 2026-05-05 | 3.52 | 3.56 | 3.32 | 3.37 | 13.32M | -4.26% |
| 2026-05-04 | 3.40 | 3.55 | 3.39 | 3.52 | 10.17M | +3.83% |
| 2026-05-01 | 3.46 | 3.50 | 3.36 | 3.39 | 12.00M | -2.02% |
| 2026-04-30 | 3.33 | 3.59 | 3.27 | 3.46 | 12.99M | +4.85% |
| 2026-04-29 | 3.37 | 3.39 | 3.21 | 3.30 | 11.97M | -3.23% |
| 2026-04-28 | 3.40 | 3.50 | 3.38 | 3.41 | 8.84M | -2.01% |
| 2026-04-27 | 3.46 | 3.59 | 3.44 | 3.48 | 10.50M | -0.85% |
| 2026-04-24 | 3.50 | 3.57 | 3.46 | 3.51 | 9.29M | +0.29% |
| 2026-04-23 | 3.70 | 3.71 | 3.43 | 3.50 | 11.03M | -6.17% |
| 2026-04-22 | 3.61 | 3.73 | 3.61 | 3.73 | 10.14M | +4.78% |
| 2026-04-21 | 3.70 | 3.74 | 3.55 | 3.56 | 11.79M | -3.52% |
| 2026-04-20 | 3.70 | 3.80 | 3.66 | 3.69 | 9.71M | -2.38% |
| 2026-04-17 | 3.72 | 3.88 | 3.71 | 3.78 | 13.94M | +5.00% |
| 2026-04-16 | 3.85 | 3.90 | 3.53 | 3.60 | 16.17M | -4.00% |
| 2026-04-15 | 3.57 | 3.75 | 3.56 | 3.75 | 11.80M | +5.93% |
| 2026-04-14 | 3.48 | 3.55 | 3.46 | 3.54 | 8.92M | +3.51% |
| 2026-04-13 | 3.24 | 3.43 | 3.23 | 3.42 | 8.67M | +4.17% |
| 2026-04-10 | 3.32 | 3.38 | 3.24 | 3.28 | 8.57M | -0.82% |
| 2026-04-09 | 3.33 | 3.44 | 3.27 | 3.31 | 8.62M | -2.36% |
| 2026-04-08 | 3.39 | 3.46 | 3.29 | 3.39 | 15.53M | +6.27% |
| 2026-04-07 | 3.11 | 3.20 | 3.04 | 3.19 | 10.05M | +1.53% |
| 2026-04-06 | 3.11 | 3.22 | 3.11 | 3.14 | 8.31M | +1.03% |
| 2026-04-02 | 2.92 | 3.13 | 2.91 | 3.11 | 9.22M | +1.63% |
| 2026-04-01 | 3.13 | 3.21 | 3.04 | 3.06 | 10.78M | -0.33% |
| 2026-03-31 | 2.90 | 3.07 | 2.90 | 3.07 | 13.69M | +8.10% |
| 2026-03-30 | 2.93 | 2.94 | 2.80 | 2.84 | 16.64M | -3.40% |
| 2026-03-27 | 3.10 | 3.12 | 2.91 | 2.94 | 18.92M | -6.67% |
| 2026-03-26 | 3.10 | 3.26 | 3.10 | 3.15 | 9.36M | -0.63% |
See RXRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RXRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RXRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRXRX — Frequently Asked Questions
Quick answers to the most common questions about buying RXRX stock.
How has RXRX stock performed recently?
RXRX declined -22.0% over the past year, below its 5-year annualized CAGR of -34.8%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is RXRX's all-time high price?
Recursion Pharmaceuticals, Inc. reached $42.81 on 2021-07-13. The 52-week high is $7.18. Current 1-year return of -22.0% places the stock further from historical peaks.
Where can I download RXRX historical price data?
This page provides RXRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.